RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 48 filers reported holding RECRO PHARMA INC in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $146,890 | -68.5% | 313,198 | -26.0% | 0.00% | -62.5% |
| Q2 2023 | $465,773 | -60.1% | 423,430 | -56.8% | 0.01% | -63.6% |
| Q1 2023 | $1,167,730 | -24.6% | 981,286 | -5.6% | 0.02% | -31.2% |
| Q4 2022 | $1,548,135 | -8.6% | 1,039,017 | 0.0% | 0.03% | -11.1% |
| Q3 2022 | $1,694,000 | +107.3% | 1,039,017 | +1.1% | 0.04% | +125.0% |
| Q2 2022 | $817,000 | -55.8% | 1,028,132 | +0.1% | 0.02% | -46.7% |
| Q1 2022 | $1,849,000 | +3.4% | 1,027,132 | -1.8% | 0.03% | +11.1% |
| Q4 2021 | $1,788,000 | -25.1% | 1,045,774 | -9.7% | 0.03% | -27.0% |
| Q3 2021 | $2,386,000 | -3.4% | 1,158,479 | +8.3% | 0.04% | 0.0% |
| Q2 2021 | $2,470,000 | +7.5% | 1,069,383 | +29.9% | 0.04% | -2.6% |
| Q1 2021 | $2,297,000 | +57.9% | 823,446 | +61.3% | 0.04% | +46.2% |
| Q4 2020 | $1,455,000 | – | 510,569 | – | 0.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samjo Capital LLC | 8,039,100 | $3,770,338 | 1.48% |
| First Light Asset Management, LLC | 19,676,396 | $9,228,230 | 0.88% |
| AWM Investment Company, Inc. | 10,266,144 | $4,814,822 | 0.71% |
| Caligan Partners LP | 1,689,768 | $794,191 | 0.36% |
| HighMark Wealth Management LLC | 484,985 | $227,458 | 0.19% |
| Nantahala Capital Management | 1,250,000 | $586,250 | 0.05% |
| Clear Harbor Asset Management, LLC | 938,847 | $440,319 | 0.05% |
| DRIEHAUS CAPITAL MANAGEMENT LLC | 4,249,229 | $1,992,888 | 0.03% |
| TITLEIST ASSET MANAGEMENT, LLC | 210,148 | $98,559 | 0.02% |
| ROYCE & ASSOCIATES LP | 3,285,082 | $1,540,703 | 0.02% |